RECRUITING

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Official Title

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Quick Facts

Study Start:2023-09-19

Study Completion:2099-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06100991

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* A subject must meet all the following criteria to participate in the registry: 1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner. 2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted. 3. Is willing to provide consent for participation in the registry. 4. Is willing to provide Personal Information	* Any of the following would exclude the subject from participating in the registry: 1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP. 2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Inclusion Criteria

Exclusion Criteria

* A subject must meet all the following criteria to participate in the registry:
1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
3. Is willing to provide consent for participation in the registry.
4. Is willing to provide Personal Information

* Any of the following would exclude the subject from participating in the registry:
1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.
2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Contacts and Locations

Study Contact

Cathy Cheney

CONTACT

+1 508 408 5433

corevitasregistrytrials@corevitas.com

Jeffrey Greenberg, MD

CONTACT

Study Locations (Sites)

CorEvitas, LLC

Waltham, Massachusetts, 02451

United States

Collaborators and Investigators

Sponsor: CorEvitas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-19

Study Completion Date2099-12

Study Record Updates

Study Start Date2023-09-19

Study Completion Date2099-12

Terms related to this study

Additional Relevant MeSH Terms

Generalized Pustular Psoriasis